30
Participants
Start Date
October 31, 2010
Primary Completion Date
December 31, 2011
Study Completion Date
December 31, 2011
AbelaDrug200
IV 200 ml 28%drug in D5W every six hours, 10 min. duration, until ICP \< 20 mmHg, then IV 100 ml same schedule for 24 hours
mannitol
mannitol plus standard treatment
RECRUITING
Ohio State University, Columbus
RECRUITING
University of California, Irvine, Irvine
ACTIVE_NOT_RECRUITING
Boston University Medical Center, Boston
Lead Sponsor
Ohio State University
OTHER
University of California, Irvine
OTHER
Dr. Mahajan's Hospital & Industrial Trauma Centre
OTHER
Abela Pharmaceuticals, Inc.
INDUSTRY